6505--Melatonin Tablets Effective 09/15/26 - 09/14/27

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0015) for the procurement of melatonin capsules and tablets. This unrestricted contract will supply multiple federal healthcare entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded to a single responsible offeror capable of providing a continuous supply of melatonin products distributed through respective Pharmaceutical Prime Vendor programs. The initial contract term is one year with four additional one-year option periods. Offerors are required to provide melatonin in specific packaging configurations, with safety caps and labeling consistent with detailed specifications, including unique NDC/UPC identifiers that must not be altered or obscured by contractors' labels. Offerors must submit one sample bottle with the proposed label for each of the three line items differing in dosages (1mg, 3mg, and 5mg) and respective unit quantities. These samples are critical for evaluation and must be received by the offer submission deadline to be considered. The solicitation, following FAR Part 12 commercial item acquisition guidelines, is expected to be released in early March 2026 with a closing date later that same month. Estimated annual demand includes over 1.8 million bottles across the three dosage levels, with the highest volume being the 3mg capsules/tablets. Interested parties should monitor SAM.gov for updates and direct inquiries to the designated contract specialist.